California SB1023 ensures coverage for FDA-approved antiretroviral drugs, devices, and products for HIV/AIDS prevention.

California SB1023 mandates that health care service plans and health insurers cover FDA-approved antiretroviral drugs, devices, and products for HIV/AIDS prevention, including preexposure and postexposure prophylaxis. It prohibits these plans and insurers from requiring prior authorization or step therapy for these medications unless at least one therapeutic equivalent is covered without such requirements. The bill also ensures that pharmacists can dispense these drugs without restriction.

California SB1023 ensures coverage for FDA-approved antiretroviral drugs, devices, and products for HIV/AIDS prevention.

California SB1023 mandates that health care service plans and health insurers cover FDA-approved antiretroviral drugs, devices, and products for HIV/AIDS prevention, including preexposure and postexposure prophylaxis. It prohibits these plans and insurers from requiring prior authorization or step therapy for these medications unless at least one therapeutic equivalent is covered without such requirements. The bill also ensures that pharmacists can dispense these drugs without restriction.